Skip to main content
Publication date
2017 03 11
Authors
Neoptolemos, JP Palmer, DH Ghaneh, P Psarelli, EE Valle, JW Halloran, CM Faluyi, O O'Reilly, DA Cunningham, D Wadsley, J Darby, S Meyer, T Gillmore, R Anthoney, A Lind, P Glimelius, B Falk, S Izbicki, JR Middleton, GW Cummins, S Ross, PJ Wasan, H McDonald, A Crosby, T Ma, YT Patel, K Sherriff, D Soomal, R Borg, D Sothi, S Hammel, P Hackert, T Jackson, R Buchler, MW
Group authors
European Study Grp Pancreat Canc
Author KI Usernames
Lind, P|pelind
Pubmed ID
28129987
Journal
Lancet (London, England)
Doctype
Article
KI Connection
Låg
Mesh SV
Antimetaboliter vid cancerterapi Behandlingsresultat Bukspottkörteltumörer Deoxicytidin Duktalt pankreaskarcinom Kapecitabin Kaplan-Meiers skattning Kombinationsterapi med cellgifter Kvinnlig Läkemedelsterapi, understödjande Manlig Medelålders personer Människa Vuxna Äldre Äldre, 80 och över
Mesh EN
Antimetabolites, Antineoplastic Antineoplastic Combined Chemotherapy Protocols Capecitabine Carcinoma, Pancreatic Ductal Chemotherapy, Adjuvant Deoxycytidine Kaplan-Meier Estimate Pancreatic Neoplasms Treatment Outcome
First date
2017-03-26T10:49:58.749Z